Want to keep yourself up to date with the latest news from MesotheliomaHope.com?
Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.
You can unsubscribe at any time painlessly.
Title of MesotheliomaHope.com: "Mesothelioma Hope | Providing Hope for Patients & Families"
Is this your feed? Claim it!
Researchers are seeing encouraging progress with RSO-021, an experimental targeted therapy being studied for mesothelioma. The drug has now finished the second phase of its clinical trial, and researchers plan to share the results later this year.
Early results published in Nat...
Every new mesothelioma treatment starts with the same goal: giving patients more options and better outcomes. One of the most promising areas of research relates to treatments that boost the immune system, as researchers study new ways to help it recognize and attack mesothelioma.
This includes an...
Most people associate mesothelioma with job sites like shipyards, factories, and construction crews. But a growing number of patients have never worked around asbestos at all.
Their exposure came from something far more personal:
In 2001, Ellen Patton visited her doctor after she started having trouble breathing. She never expected that visit would lead to a pleural mesothelioma diagnosis.
Surgeons opened her up, planning to remove the cancer, and found it had already spread too far. The only other main treatment o...
Insilico Medicine announced on January 22, 2025, that a mesothelioma patient had received the first dose of its new treatment, ISM6331, in an ongoing phase I trial. Since then, the drug has continued to make progress.
On July 29, 2026, the U.S. Food and Drug Administration (FDA) granted ISM6331 Fast Track Designation for advanced mesothelioma, and Insi...